Report of Foreign Issuer (6-k)
March 14 2017 - 4:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of, March 2017
Commission File Number 001-37652
Midatech Pharma PLC
(Translation of registrant’s name into English)
65 Innovation Drive
Milton Park
Abingdon, Oxfordshire, OX14 4RQ, United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SUBMITTED HEREWITH
Attached to the Registrant’s Form 6-K filing for the month of March 2017, and incorporated by reference herein, is:
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press release, dated March 14, 2016 entitled “Notice of Preliminary Results.”
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Midatech Pharma PLC
|
|
|
|
|
|
|
Date: March 14, 2017
|
By:
|
/s/ Nicholas Robbins-Cherry
|
|
|
|
|
|
Nicholas Robbins-Cherry
|
|
|
Chief Financial Officer
|
|
|
|
Exhibit Index
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press release, dated March 14, 2016 entitled “Notice of Preliminary Results.”
|
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Sep 2023 to Sep 2024